Clinical Trial Update: Observational, Multi-Center Study of the Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in the Russian Federation

View source ↗

Summary

Observational real-world study of the effectiveness of Paritaprevir/ritonavir, Ombitasvir, with or without Dasabuvir and Ribavirin in chronic hepatitis C patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Dasabuvir (dasabuvir)
• Ombitasvir (ombitasvir)
• Paritaprevir/ritonavir (paritaprevir/ritonavir)
• Ribavirin (ribavirin)

Snippet

Sponsor: AbbVie | Conditions: Chronic Hepatitis C, Genotype 1 | Status: COMPLETED | Results posted: 2018-11-14